Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

Ilex and LeukoSite form joint venture for development of Campath-1H

May 14, 1997

Ono-4007 restores immune responses in tumor-bearing animals

May 12, 1997

Natural cancer immunotherapeutic discovered by Yonsei University researchers

May 9, 1997

Chiron and Biomira enter partnership for Theratope cancer vaccine

May 8, 1997

Immunomedics files IND for humanized lymphoma antibody

May 7, 1997

Amarillo Biosciences initiates clinical trial with interferon alfa in bone marrow disorders

April 28, 1997

Altarex receives funding for photodynamic therapy for ovarian cancer research

April 28, 1997

Bioniche reports positive clinical results for Regressin

April 25, 1997

BTG licenses Campath-1H to LeukoSite

April 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...